Q2 2023 Medigene AG Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome and thank you for joining the Medigene AG half-year 2023 earnings call. (Operator Instructions)
I would now like to turn the conference over to Pamela Keck, Head of IR. Please go ahead, madam.
Welcome, everyone, and thank you for joining us. With me today is Dr. Selwyn Ho, CEO of Medigene AG. Today, we announced financial results for the half year ended June 30, 2023. You can access the press release on the Investor Relations page of our website at medigene.com.
Before we get started, let's quickly run through the forward-looking statements. Please note that as part of our discussion today, management will be making forward-looking statements. Also, we believe our expectations are based on reasonable assumptions. By their very nature, forward-looking statements involve risks and uncertain piece and may be influenced by factors that could cause the actual results to differ materially from those expressed or implied by these
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |